Innovation in osteoporosis diagnosis Demetech develops, manufactures and markets systems for the diagnosis and early detection of osteoporosis. We offer the most accurate and reliable systems available, with comprehensive training, support, service and maintenance. DXL, Dual X-ray and Laser, is the proprietary technology that gives superior reliability through unsurpassed accuracy and precision. DXL Calscan is our first instrument based on this technology. Demetech´s ambition is to lead the technological development in osteoporosis diagnosis through constant innovation and close customer contact. Through this innovation it's now possible to diagnose and categorize patients early, which will ultimately enable prevention of osteoporosis. Key facts    2005 Scanflex International AB acquires Demetech AB 2004 FDA clearance for the DXL Calscan 2002 DXL Calscan launch in Europe 2001 DXL Calscan launch in Sweden 2001 Full quality assurance system approved 2000 Key clinical study on accuracy published 1999 Third generation DXL Calscan enters clinical trials 1998 Second generation DXL Calscan enters clinical trials 1997 Core patent approval 1997 First generation DXL Calscan enters clinical trials 1996 Demetech founded